Harbour Trust & Investment Management Co lowered its position in shares of Danaher Co. (NYSE:DHR – Free Report) by 2.8% in the 4th quarter, HoldingsChannel reports. The firm owned 4,130 shares of the conglomerate’s stock after selling 120 shares during the quarter. Harbour Trust & Investment Management Co’s holdings in Danaher were worth $948,000 at the end of the most recent reporting period.
A number of other institutional investors also recently made changes to their positions in DHR. FMR LLC raised its position in Danaher by 15.8% during the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock valued at $6,566,116,000 after purchasing an additional 3,217,631 shares during the last quarter. Massachusetts Financial Services Co. MA raised its holdings in Danaher by 17.6% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate’s stock worth $996,141,000 after acquiring an additional 535,254 shares during the last quarter. International Assets Investment Management LLC lifted its position in Danaher by 40,196.5% in the 3rd quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate’s stock valued at $119,539,000 after acquiring an additional 428,897 shares in the last quarter. Montrusco Bolton Investments Inc. increased its holdings in shares of Danaher by 30.4% in the 3rd quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate’s stock worth $465,617,000 after purchasing an additional 397,671 shares in the last quarter. Finally, Union Bancaire Privee UBP SA purchased a new position in shares of Danaher in the fourth quarter worth $74,551,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Analysts Set New Price Targets
Several analysts recently commented on DHR shares. Robert W. Baird cut their price objective on Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Wells Fargo & Company lowered their target price on Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 30th. Citigroup decreased their target price on Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a research note on Thursday, January 30th. Barclays lowered their price objective on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. Finally, TD Cowen raised their price target on Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Seven analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $278.00.
Insider Buying and Selling
In related news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 11.10% of the company’s stock.
Danaher Stock Down 1.5 %
NYSE:DHR opened at $206.92 on Monday. The firm has a market capitalization of $149.45 billion, a P/E ratio of 39.19, a PEG ratio of 2.68 and a beta of 0.83. The company’s fifty day moving average price is $232.72 and its 200-day moving average price is $251.70. Danaher Co. has a 1-year low of $205.79 and a 1-year high of $281.70. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the firm posted $2.09 earnings per share. As a group, equities research analysts anticipate that Danaher Co. will post 7.67 EPS for the current year.
Danaher Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were given a dividend of $0.27 per share. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.52%. Danaher’s dividend payout ratio is currently 20.45%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
- Five stocks we like better than Danaher
- Stock Average Calculator
- 3 Volatility ETFs to Help You Profit from Market Chaos
- Bank Stocks – Best Bank Stocks to Invest In
- Lam Research: Is a NAND Upgrade Cycle the Next Growth Catalyst?
- How to Profit From Growth Investing
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.